• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of rapid amyloid and phosphorylated‐Tau accumulation in cognitively healthy individuals.认知健康个体中快速淀粉样蛋白和磷酸化tau蛋白积累的预测
Alzheimers Dement (Amst). 2020 Mar 22;12(1):e12019. doi: 10.1002/dad2.12019. eCollection 2020.
2
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.阿尔茨海默病中脑脊液淀粉样蛋白-β与氟代硼吡咯(florbetapir)成像的独立信息
Brain. 2015 Mar;138(Pt 3):772-83. doi: 10.1093/brain/awu367. Epub 2014 Dec 24.
3
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.阿尔茨海默病标准化脑脊液生物标志物在澳大利亚成像、生物标志物和生活方式(AIBL)研究中经PET淀粉样β蛋白特征化的受试者中得到验证。
J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.
4
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.在女性和淀粉样蛋白阳性的年轻受试者中,tau 聚集物的积累速度更高。
Brain. 2020 Dec 1;143(12):3805-3815. doi: 10.1093/brain/awaa327.
5
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
6
Sex modulates the ApoE ε4 effect on brain tau deposition measured by F-AV-1451 PET in individuals with mild cognitive impairment.性别调节载脂蛋白 E ε4 对轻度认知障碍个体脑 Tau 沉积的影响,通过 F-AV-1451 PET 进行测量。
Theranostics. 2019 Jul 9;9(17):4959-4970. doi: 10.7150/thno.35366. eCollection 2019.
7
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
8
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.淀粉样-β PET 和 CSF 生物标志物不一致及其临床后果。
Alzheimers Res Ther. 2019 Sep 12;11(1):78. doi: 10.1186/s13195-019-0532-x.
9
Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.认知正常的老年人中阿尔茨海默病脑脊液生物标志物与认知的关系。
Neuropsychologia. 2015 Nov;78:63-72. doi: 10.1016/j.neuropsychologia.2015.09.024. Epub 2015 Sep 21.
10
Subthreshold Amyloid Predicts Tau Deposition in Aging.亚阈值淀粉样蛋白可预测衰老中的 Tau 沉积。
J Neurosci. 2018 May 9;38(19):4482-4489. doi: 10.1523/JNEUROSCI.0485-18.2018. Epub 2018 Apr 23.

引用本文的文献

1
A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment.使用快球记忆评估对轻度认知障碍中的识别记忆进行被动和客观测量。
Brain Commun. 2025 Sep 1;7(5):fcaf279. doi: 10.1093/braincomms/fcaf279. eCollection 2025.
2
Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline.基于体素的早期阿尔茨海默病病理进展洞察:与载脂蛋白E及记忆衰退的关联
Geroscience. 2025 Apr 1. doi: 10.1007/s11357-025-01610-z.
3
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
4
ɛ4 exacerbates age-dependent deficits in cortical microstructure.ε4加剧了皮质微结构中与年龄相关的缺陷。
Brain Commun. 2024 Feb 21;6(1):fcad351. doi: 10.1093/braincomms/fcad351. eCollection 2024.
5
Directed Functional Brain Connectivity is Altered in Sub-threshold Amyloid-β Accumulation in Cognitively Normal Individuals.认知正常个体中,阈下淀粉样β蛋白积累会改变定向功能性脑连接。
Neurosci Insights. 2023 Mar 29;18:26331055231161625. doi: 10.1177/26331055231161625. eCollection 2023.
6
A multidimensional ODE-based model of Alzheimer's disease progression.基于多维 ODE 的阿尔茨海默病进展模型。
Sci Rep. 2023 Feb 23;13(1):3162. doi: 10.1038/s41598-023-29383-5.
7
Neurodegenerative disease of the brain: a survey of interdisciplinary approaches.脑的神经退行性疾病:跨学科方法的调查。
J R Soc Interface. 2023 Jan;20(198):20220406. doi: 10.1098/rsif.2022.0406. Epub 2023 Jan 18.
8
Longitudinal change in ATN biomarkers in cognitively normal individuals.认知正常个体中 ATN 生物标志物的纵向变化。
Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6.
9
Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.社区居住的老年人的嗅觉、认知障碍和 PET 生物标志物。
J Alzheimers Dis. 2022;86(3):1275-1285. doi: 10.3233/JAD-210636.
10
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.系统评价:微小RNA作为轻度认知障碍诊断中的潜在生物标志物
Front Aging Neurosci. 2022 Jan 12;13:807764. doi: 10.3389/fnagi.2021.807764. eCollection 2021.

本文引用的文献

1
Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults.最初淀粉样蛋白阴性的成年人中区域性淀粉样蛋白的积累与认知能力下降。
Neurology. 2018 Nov 6;91(19):e1809-e1821. doi: 10.1212/WNL.0000000000006469. Epub 2018 Oct 10.
2
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers.事件性认知障碍:分子、结构和认知生物标志物的纵向变化。
Brain. 2018 Nov 1;141(11):3233-3248. doi: 10.1093/brain/awy244.
3
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.浅析影响阿尔茨海默病诊断中脑脊髓液生物标志物检测的分析前变量
Alzheimers Dement. 2018 Oct;14(10):1313-1333. doi: 10.1016/j.jalz.2018.05.008. Epub 2018 Jun 23.
4
Subthreshold Amyloid Predicts Tau Deposition in Aging.亚阈值淀粉样蛋白可预测衰老中的 Tau 沉积。
J Neurosci. 2018 May 9;38(19):4482-4489. doi: 10.1523/JNEUROSCI.0485-18.2018. Epub 2018 Apr 23.
5
Memory decline accompanies subthreshold amyloid accumulation.记忆衰退伴随着亚阈值淀粉样蛋白积累。
Neurology. 2018 Apr 24;90(17):e1452-e1460. doi: 10.1212/WNL.0000000000005354. Epub 2018 Mar 23.
6
The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.临床前阿尔茨海默病中脑脊液Aβ42与tau之间的非线性关系。
PLoS One. 2018 Feb 7;13(2):e0191240. doi: 10.1371/journal.pone.0191240. eCollection 2018.
7
Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases.使用协调图谱进行基于多图谱的脑解剖结构的纵向和站点间一致性分割。
Neuroimage. 2018 Feb 1;166:71-78. doi: 10.1016/j.neuroimage.2017.10.026. Epub 2017 Nov 4.
8
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease.出现淀粉样蛋白阳性的时间以及脑代谢、萎缩和认知方面的临床前变化:阿尔茨海默病中新兴淀粉样蛋白病理学的证据。
Front Neurosci. 2017 May 17;11:281. doi: 10.3389/fnins.2017.00281. eCollection 2017.
9
Suspected non-Alzheimer disease pathophysiology--concept and controversy.疑似非阿尔茨海默病的病理生理学——概念与争议
Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18.
10
MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection.MUSE:利用配准算法和参数集合以及局部最优图谱选择的多图谱区域分割
Neuroimage. 2016 Feb 15;127:186-195. doi: 10.1016/j.neuroimage.2015.11.073. Epub 2015 Dec 8.

认知健康个体中快速淀粉样蛋白和磷酸化tau蛋白积累的预测

Prediction of rapid amyloid and phosphorylated‐Tau accumulation in cognitively healthy individuals.

作者信息

Koychev Ivan, Vaci Nemanja, Bilgel Murat, An Yang, Muniz Graciela Terrera, Wong Dean F, Gallacher John, Mogekhar Abhay, Albert Marilyn, Resnick Susan M

机构信息

Department of Psychiatry University of Oxford Oxford UK.

Laboratory of Behavioral Neuroscience National Institute on Aging National Institutes of Health Baltimore Maryland.

出版信息

Alzheimers Dement (Amst). 2020 Mar 22;12(1):e12019. doi: 10.1002/dad2.12019. eCollection 2020.

DOI:10.1002/dad2.12019
PMID:32211504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7086102/
Abstract

OBJECTIVE

To test the hypothesis that among cognitively healthy individuals, distinct groups exist in terms of amyloid and phosphorylated-tau accumulation rates; that if rapid accumulator groups exist, their membership can be predicted by Alzheimer's disease (AD) risk factors, and that time points of significant increase in AD protein accumulation will be evident.

METHODS

The analysis reports data from 263 individuals from the BIOCARD and 184 individuals from the Baltimore Longitudinal Study of Aging with repeated cerebrospinal fluid (CSF) and positron emission tomography (PET) sampling, respectively. We used latent class mixed-effect models to identify distinct classes of amyloid (CSF and PET) and p-Tau (CSF) accumulation rates and generalized additive modeling to investigate non-linear changes to AD biomarkers.

RESULTS

For both amyloid and p-Tau latent class models we confirmed the existence of two separate classes: accumulators and non-accumulators. The accumulator and non-accumulator groups differed significantly in terms of baseline AD protein levels and slope of change. ε4 carrier status and episodic memory predicted amyloid class membership. Non-linear models revealed time points of significant increase in the rate of amyloid and p-Tau accumulation whereby ε4 carrier status associated with earlier age at onset of rapid accumulation.

CONCLUSIONS

The current analysis demonstrates the existence of distinct classes of amyloid and p-Tau accumulators. Predictors of class membership were identified but the overall accuracy of the models was modest, highlighting the need for additional biomarkers that are sensitive to early disease phenotypes.

摘要

目的

检验以下假设:在认知健康个体中,存在不同的淀粉样蛋白和磷酸化tau蛋白积累率分组;如果存在快速积累者分组,其成员可通过阿尔茨海默病(AD)风险因素预测,且AD蛋白积累显著增加的时间点将很明显。

方法

该分析报告了分别来自BIOCARD的263名个体和巴尔的摩衰老纵向研究的184名个体的数据,他们分别进行了重复的脑脊液(CSF)和正电子发射断层扫描(PET)采样。我们使用潜在类别混合效应模型来识别淀粉样蛋白(CSF和PET)和p-Tau(CSF)积累率的不同类别,并使用广义相加模型来研究AD生物标志物的非线性变化。

结果

对于淀粉样蛋白和p-Tau潜在类别模型,我们都证实存在两个不同的类别:积累者和非积累者。积累者和非积累者组在基线AD蛋白水平和变化斜率方面存在显著差异。ε4携带者状态和情景记忆可预测淀粉样蛋白类别成员。非线性模型揭示了淀粉样蛋白和p-Tau积累率显著增加的时间点,其中ε4携带者状态与快速积累开始的较早年龄相关。

结论

当前分析表明存在不同类别的淀粉样蛋白和p-Tau积累者。已确定类别成员的预测因素,但模型的总体准确性一般,这突出表明需要对早期疾病表型敏感的其他生物标志物。